Gastrointestinal Cancer News

In certain settings.

Sepsis is a leading cause of preventable death across the globe, and patients with cancer have a 10 times higher likelihood of developing this life-threatening condition than those without cancer.

Although cancer clinical trial participation has increased among Black and Hispanic individuals, these populations — along with women and older adults — remained underrepresented, according to a study published in Cancer.

The FDA granted orphan drug designation to toripalimab for the treatment of esophageal cancer.

The FDA granted orphan drug designation to DF1001 for treatment of esophageal cancer.

The FDA granted orphan drug designation to rivoceranib for the treatment of hepatocellular carcinoma.

Opioid use among people dying of cancer declined substantially from 2007 to 2017, according to study results published in Journal of Clinical Oncology.

More than 80% of therapies tested in phase 3 oncology trials did not demonstrate clinically meaningful benefit in extending survival, according to results of a study published in JNCCN — Journal of the National Comprehensive Cancer Network.

Use of a transforming growth factor-beta pathway-based combinatorial serum protein panel may aid in the early detection of hepatocellular carcinoma, according to research presented at The Liver Meeting Digital Experience.

A cyclic, 5-day fasting-mimicking diet appeared safe and showed potential to improve outcomes among patients on anticancer therapy for different tumor types, according to study results published in Cancer Discovery.